MAPS MAPS
  • About
  • Research
  • News
  • Resources
  • Participate
  • Donate
  • Store

LSD Research News Timeline

Filters
List of articles in category LSD Research News Timeline
Title Published Date
Switzerland: Qualitative Results Published, Showing Lasting Benefits November 11, 2014
Paper Resubmitted for Publication after Editorial Rejection July 21, 2014
LSD Study Breaks 40 Years of Research Taboo July 21, 2014
LSD Annual Report Submitted to FDA July 21, 2014
Switzerland: Results Published in Journal of Nervous Mental Disease July 5, 2014
Switzerland: Paper Accepted for Publication in Journal of Nervous and Mental Disease February 18, 2014
Final Report Submitted to SwissMedic January 21, 2014
Results Submitted for Publication in Peer-Reviewed Journal January 21, 2014
LSD-Assisted Psychotherapy for Anxiety Associated with Advanced Illness: Closeout Visit Conducted September 7, 2012
LSD-Assisted Psychotherapy for Anxiety: Last Follow-Up Interviews Complete August 8, 2012
Shaping the Renaissance of Psychedelic Research July 21, 2012
LSD-Assisted Psychotherapy for End-of-Life Anxiety: Annual Report Submitted to FDA May 2, 2012
Last Two-Month Follow-Up Completed in Swiss Study of LSD Psychotherapy Study October 21, 2011
Last Subject Treated in Swiss Study of LSD-Assisted Psychotherapy for End-of-Life Anxiety May 26, 2011
Swiss LSD Study Team Submits Annual Report to FDA; Study Nears Completion May 3, 2011
Swiss LSD Study in Final Stages February 17, 2011
Twelfth and Final Subject Enrolled in Swiss LSD Study January 11, 2011
Twelfth and Final Subject to be Screened for Swiss LSD Study December 17, 2010
MAPS Grants $10K to Beckley Psilocybin/Brain Imaging Study September 30, 2010
Swiss IRB Approves Subjects with Life-Shortening Illnesses: Parkinsons and Bechterews Disease September 17, 2010
LSD and Psilocybin Related Documents and Resources June 29, 2010
Psilocybin-Assisted Psychotherapy in the Treatment of Anxiety Secondary to Advanced Stage Cancer June 29, 2010
New Database Prepared for LSD-Study in Accordance with FDA Best Practices June 28, 2010
LSD-Assisted Psychotherapy for Anxiety Associated with Life-Threatening Illness June 25, 2010
Swiss LSD/End-of-Life Anxiety Study Moving Forward; Protocol Amendment Accepted by IRB June 22, 2010
Amendment to LSD Protocol Submitted to Swiss Ethics Committee May 4, 2010
Eighth Subject Enrolled in LSD Trial December 17, 2009
Swiss LSD Study is Renewed for Another Year by SwissMedic December 3, 2009
Sixth Subject Enrolled in LSD Study October 26, 2009
"Inside LSD" Broadcast on National Geographi October 12, 2009
LSDs long strange trip back into the lab September 27, 2009
We submitted to the FDA the August 31, 2009
Swiss LSD/End-of-Life Study Receives $25,695 April 8, 2009
LSD-Assisted Psychotherapy for 12 People with Anxiety Related to Life-Threatening Illness December 9, 2008
Swiss LSD/End-of-Life Anxiety Study Annual Report Completed November 25, 2008
MAPS Transfers $25,000 To The Swiss LSD Study November 3, 2008
FDA Removes Clinical Hold on LSD Research - A Transformative Moment in Psychedelic History September 26, 2008
Benefits of Magic Mushroom Therapy Long Lasting July 3, 2008
A Really Long Strange Trip July 2, 2008
Psilocybin Study Hints at Rebirth of Hallucinogen Research July 1, 2008
Study finds long benefit in illegal mushroom drug July 1, 2008
From MAPS: Letter to Editor of the Economist May 19, 2008
Albert Hofmann, chemist, died on April 29th, aged 102 May 8, 2008
Albert Dies, LSD Psychotherapy Research Lives May 7, 2008
Albert Hofmann Obituary May 7, 2008
On Albert Hofmann, inventor of LSD May 1, 2008
Letter LSD-assisted psychotherapy in persons suffering from anxiety December 6, 2007
Dr. Peter Gasser's MAPS-sponsored study December 5, 2007
In September, MAPS submitted an application to F November 7, 2007
MAPS President Rick Doblin, PhD, spoke at the October 30, 2007
Sheer genius: from the web to Homer Simpson October 29, 2007
A major Swiss TV news report was broadcast earli September 18, 2007
MAPS Swiss LSD Study Featured in Major Swiss TV News Report September 18, 2007
Later this week, MAPS will submit an application September 17, 2007
Yesterday, Peter Gasser, MD, received final appr July 13, 2007
Dr. Peter Gasser submitted his protocol to the March 21, 2007
The Acid Test February 19, 2007
Cluster Busters December 28, 2006
Psychedelic drug hope for OCD December 11, 2006
Chronic Cluster Headaches Responding to Psilocybin November 6, 2006
The Spanish-language journal Revista de Neurolog November 6, 2006
The Globe and Mail: The LSD Treatment October 16, 2006
Dropping acid may help headaches September 13, 2006
An Esalen Teaching Story July 20, 2006
On Tuesday, July 11, a National Institute on Dru July 11, 2006
Results of Dr. Andrew Sewell and Dr. John Halper June 28, 2006
A Personal Account of a Woman Who Overcame Her Cigarette Addition During an LSD Experience April 27, 2006
The Guardian (UK): Lancet Calls for LSD in Labs April 14, 2006
The Lancet: Reviving Research into Psychedelic Drugs April 14, 2006
St. Albert and the LSD Revelation Revolution March 3, 2006
LSD for Cancer? February 5, 2006
Headache Sufferers Flout New Drug Law August 2, 2005
The Acid Test January 13, 2005
Mail on Sunday: Nobel Prize Genius Crick Was High on LSD When He Discovered the Secret of Life August 8, 2004
This is the 61st anniversary of the world's firs April 19, 2004
A Critical Review of Theories and Research Concerning LSD August 25, 1999
Follow-up Study of Janiger LSD Research May 9, 1999

Stay Connected via Email

Subscribe for research updates, event announcements, news, multimedia, and more from the fast-growing fields of psychedelic and medical marijuana science, therapy, and spirituality.

Your email address:


Support Us

Donate Now

MAPS

We are a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Watch videos from Psychedelic Science 2017.

Media

  • February 19, 2021 NBC: New California Bill Would Decriminalize Psychedelics, Expunge Criminal Records
  • February 18, 2021 Lucid News: Jade Ullmann is Bridging Together Psychedelic Communities
  • February 18, 2021 Statement: California State Legislator Introduces Bill to Decriminalize Psychedelics

About Us

  • Mission
  • Board of Directors
  • Staff
  • Financial Reports
  • MAPS Public Benefit Corporation (MAPS PBC)
  • 501(c)(3) & Bylaws
  • FAQ

Contact Us

3141 Stevens Creek Blvd #40563
San Jose, CA 95117
Phone: 831-429-MDMA (6362)
Fax: 831-429-6370
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Requests

Log in to your account


Privacy Policy | Donate

facebook twitter instagram
youtube linkedin
  • About
    • Mission
    • Board of Directors
    • Staff
    • Financial Reports
    • MAPS Public Benefit Corporation (MPBC)
    • 501(c)(3), EIN, and Bylaws
    • Privacy Policy
    • FAQ
  • Research
    • MDMA-Assisted Therapy
    • LSD-Assisted Psychotherapy
    • Ibogaine Therapy for Drug Addiction
    • Ayahuasca-Assisted Treatment
    • Medical Marijuana
    • Other Psychedelic Research
    • Research articles
  • News
    • MAPS Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • MAPS Podcast
    • Multimedia Library
    • Posts
    • MAPS Podcast
    • Emails
  • Resources
    • Brochures
    • Psychedelic Harm Reduction
    • Research Papers
    • Psychedelic Integration List
    • Psychedelic Bibliography
    • Free Books and Essays
    • Links
    • For Students
    • MAPS Forums on Bluelight
    • Psychedelic Science 2017 Videos
  • Participate
    • Global Psychedelic Dinners
    • Featured Events
    • Event Calendar
    • Volunteer
    • Global Psychedelic Dinners
    • Internships
    • MDMA Therapy Training Program
    • Careers
    • Participate in Research
  • Donate
    • Make a Gift
    • Why Give?
    • Funding Priorities
  • Store
    • Books
    • Clothing and Accessories
    • DVDs
    • Historic Artifacts
    • Art Gallery
    • MAPS Bulletin: Back Issues